211 related articles for article (PubMed ID: 25853953)
1. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles.
Eskandani M; Barar J; Dolatabadi JE; Hamishehkar H; Nazemiyeh H
Pharm Biol; 2015; 53(10):1525-38. PubMed ID: 25853953
[TBL] [Abstract][Full Text] [Related]
2. Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect.
Nakhlband A; Eskandani M; Saeedi N; Ghafari S; Omidi Y; Barar J; Garjani A
Colloids Surf B Biointerfaces; 2018 Apr; 164():299-307. PubMed ID: 29413609
[TBL] [Abstract][Full Text] [Related]
3. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
4. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
5. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
6. Preparation, physicochemical characterization, and anti-proliferative properties of Lawsone-loaded solid lipid nanoparticles.
Rasouliyan F; Eskandani M; Jaymand M; Akbari Nakhjavani S; Farahzadi R; Vandghanooni S; Eskandani M
Chem Phys Lipids; 2021 Sep; 239():105123. PubMed ID: 34403685
[TBL] [Abstract][Full Text] [Related]
7. Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles.
Ezzati Nazhad Dolatabadi J; Hamishehkar H; Eskandani M; Valizadeh H
Colloids Surf B Biointerfaces; 2014 May; 117():21-8. PubMed ID: 24607519
[TBL] [Abstract][Full Text] [Related]
8. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
9. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study.
Chen R; Wang S; Zhang J; Chen M; Wang Y
Drug Deliv; 2015; 22(5):666-74. PubMed ID: 24512431
[TBL] [Abstract][Full Text] [Related]
10. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
11. Acriflavine-loaded solid lipid nanoparticles: preparation, physicochemical characterization, and anti-proliferative properties.
Vandghanooni S; Rasoulian F; Eskandani M; Akbari Nakhjavani S; Eskandani M
Pharm Dev Technol; 2021 Nov; 26(9):934-942. PubMed ID: 34338582
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of anticancer and antiangiogenesis efficiency of PLA-PEG nanoparticles loaded with galbanic acid in C26 colon carcinoma, in vitro and in vivo.
Afsharzadeh M; Abnous K; Yazdian-Robati R; Ataranzadeh A; Ramezani M; Hashemi M
J Cell Physiol; 2019 May; 234(5):6099-6107. PubMed ID: 30378118
[TBL] [Abstract][Full Text] [Related]
13. Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata.
Bhushan S; Kakkar V; Pal HC; Guru SK; Kumar A; Mondhe DM; Sharma PR; Taneja SC; Kaur IP; Singh J; Saxena AK
Mol Pharm; 2013 Jan; 10(1):225-35. PubMed ID: 23237302
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of l-carnitine-loaded solid lipid nanoparticles against H
Eskandani M; Eskandani M; Vandghanooni S; Navidshad B; Aghjehgheshlagh FM; Nobakht A
Colloids Surf B Biointerfaces; 2022 Apr; 212():112365. PubMed ID: 35124408
[TBL] [Abstract][Full Text] [Related]
15. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
[TBL] [Abstract][Full Text] [Related]
16. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
17. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
18. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
[TBL] [Abstract][Full Text] [Related]
20. Formulation and Physicochemical Characterization of Lycopene-Loaded Solid Lipid Nanoparticles.
Nazemiyeh E; Eskandani M; Sheikhloie H; Nazemiyeh H
Adv Pharm Bull; 2016 Jun; 6(2):235-41. PubMed ID: 27478786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
